Kawaguchi: This roundtable discussion is on the Osteoarthritis Research Society International (OARSI) treatment guidelines, of which part 1 has just been published this year and part 2 on consensus recommendations will be published early in 2008. First of all, please could you give a brief outline of the OARSI treatment guidelines, especially in comparison with the former osteoarthritis (OA) guidelines issued by the European League Against Rheumatism (EULAR) and American College of Rheumatology (ACR)?
You are here
Japanese Roundtable on Treatment Guidelines
The incidence of osteoarthritis (OA) has been increasing on a global scale. Research is under way to elucidate its causes and pathology; however, no fundamental treatment methods have been established. This roundtable discussion involved leading physicians from the USA, the UK, and Japan, who talked frankly about the current status of and outlook for OA treatment from
their respective viewpoints. Their discussion identified similarities and differences between the countries and proved to be a valuable opportunity for building international consensus on OA treatment.
Recent advances in bioscience at the molecular level and research methods have brought with them a dramatic growth in the volume of medical research conducted at various levels in ever-diversifying specializations. Orthopedics is, of course, no exception; attempts to further explore this therapeutic area have resulted in remarkable progress, with state-of-the-art research in orthopedics now embracing molecular and genetic science, bioengineering, and large-scale randomized comparative clinical studies.
This newsletter has been covering the efforts of the Osteoarthritis Research Society International (OARSI) to optimize treatment for patients with osteoarthritis (OA) worldwide. In 2008, OARSI published its expert consensus recommendations for the management of OA of the hip and knee (Part 2)1, based on an appraisal of existing guidelines and a systematic review of evidence for relevant therapies (Part 1)2.
This newsletter, first published in 2007, covers the efforts of the Osteoarthritis Research Society International (OARSI) to improve the treatment of patients with osteoarthritis (OA). Previous newsletters have covered roundtable discussions by experts on current treatments for OA, the introduction of new recommendations for treating OA, and the future of orthopedic research. This year, the Japanese Orthopaedic Association (JOA) developed Japanese knee OA guidelines based on the OARSI treatment guidelines to provide a ‘bible’ for Japanese clinicians.
- 4 days 17 hours ago.
- 5 days 15 hours ago.
By Multiple Authors